Advertisement

Organisation › Details
Evolva (Group)
Evolva is an international, innovative synthetic biology company with a world-class research platform. Evolva strives to improve people's lives by applying its technology and other resources to the discovery and development of new products and processes that benefit the health, well-being and financial economy of patients, consumers and partner companies around the world. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Our approach differs from that of the mainstream in the pharmaceutical and chemical industries. We have discovery partnerships ongoing both in pharma and in nutrition. In addition we have a pipeline of promising compounds aimed at infectious and cardio-renal indications. *
![]() |
Start | 2001-01-01 established |
![]() |
Industry | food ingredient |
Industry 2 | resveratrol | |
![]() |
Person | Waddington, Simon (Evolva 201707–201807 CEO before COO before Abunda Nutrition CEO RESIGNED 7/18) |
Person 2 | Hoetmer, Gerard (Corbion 201306 CEO) | |
![]() |
Region | Reinach BL |
Country | Switzerland | |
Street | 23 Duggingerstr. | |
City | 4153 Reinach BL | |
Tel | +41-61-485-2000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | D: 101 to 500 (2014-12-31) |
Currency | CHF | |
Annual sales | 9,600,000 (revenue, total, consolidated (2016) 2016-12-31) | |
Profit | -35,800,000 (2016-12-31) | |
Cash | 47,500,000 (2016-12-31) | |
* Document for �About Section�: | ||
Record changed: 2018-09-12 |
Advertisement
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
More documents for Evolva (Group)
- [1] Evolva Holding S.A.. (2/28/22). "Press Release: Carsten Däweritz Remains CFO of Evolva". Reinach....
- [2] Evolva Holding S.A.. (2/8/22). "Press Release: Evolva Appoints Christian Wichert as New CEO to Boost Growth Strategy and Enter Its Next Phase of Development and Commercialization". Reinach....
- [3] Evolva Holding S.A.. (12/27/21). "Press Release: Evolva Secures Additional Financing Lines to Accelerate Its Growth". Reinach....
- [4] Evolva Holding S.A.. (11/30/21). "Press Release: Evolva Announces Private Placement of 63.8m Shares to Veraison Raising Gross Proceeds of CHF 7.5m and CFO Departure". Reinach....
- [5] Evolva S.A.. (3/24/21). "Press Release: Evolva Announces New Chief Financial Officer". Reinach....
- [6] Evolva Holding S.A.. (7/10/18). "Press Release: Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO"....
- [7] Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]"....
- [8] Evolva Holding S.A.. (8/30/17). "Press Release: Evolva Announces Major Restructuring for Next Phase of Its Development"....
- [9] Evolva Holding S.A.. (8/14/17). "Press Release: Evolva Announces Financial Results for the First Half of 2017"....
- [10] Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top